|
Edward A. Stadtmauer, MD Professor of Medicine (Hematology-Oncology) Co-Leader, Hematologic Malignancies Program Director, Bone Marrow and Stem Cell Transplant Program Abramson Cancer Center University of Pennsylvania - Perelman Center for Advanced Medicine Philadelphia, Pennsylvania |
|
Ruben Niesvizky, MD Associate Professor of Medicine Weill Cornell Medical College Associate Attending Physician New York-Presbyterian Hospital New York, New York |
The opinions contained within this commentary are solely those of Edward A. Stadtmauer, MD and Ruben Niesvizky, MD and are not supported or endorsed by MediCom Worldwide, Inc., Millennium Pharmaceuticals, Inc., or Cephalon Oncology.
